These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 27760529

  • 21. Neutrophil gelatinase--associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation.
    Portal AJ, McPhail MJ, Bruce M, Coltart I, Slack A, Sherwood R, Heaton ND, Shawcross D, Wendon JA, Heneghan MA.
    Liver Transpl; 2010 Nov; 16(11):1257-66. PubMed ID: 21031541
    [Abstract] [Full Text] [Related]

  • 22. Delivered dose of continuous venovenous hemofiltration predicts outcome in septic patients with acute kidney injury: a retrospective study.
    Nurmohamed SA, Koning MV, Vervloet MG, Groeneveld AB.
    J Crit Care; 2011 Apr; 26(2):213-20. PubMed ID: 21036524
    [Abstract] [Full Text] [Related]

  • 23. [Effect of continuous renal replacement therapy on the plasma concentration of imipenem in severe infection patients with acute renal injury].
    Yu B, Liu L, Xing D, Zhao C, Hu Z.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):359-65. PubMed ID: 26003640
    [Abstract] [Full Text] [Related]

  • 24. Effect of anticoagulation regimens on handling of interleukin-6 and -8 during continuous venovenous hemofiltration in critically ill patients with acute kidney injury.
    Schilder L, Nurmohamed SA, ter Wee PM, Girbes AR, Beishuizen A, Paauw NJ, Beelen RH, Groeneveld AB.
    Cytokine; 2012 Dec; 60(3):601-7. PubMed ID: 23006672
    [Abstract] [Full Text] [Related]

  • 25. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
    Petejova N, Martinek A, Zahalkova J, Duricova J, Brozmannova H, Urbanek K, Grundmann M, Plasek J, Kacirova I.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Dec; 158(1):65-72. PubMed ID: 23132513
    [Abstract] [Full Text] [Related]

  • 26. Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI)--a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project.
    Wald R, Friedrich JO, Bagshaw SM, Burns KE, Garg AX, Hladunewich MA, House AA, Lapinsky S, Klein D, Pannu NI, Pope K, Richardson RM, Thorpe K, Adhikari NK.
    Crit Care; 2012 Oct 24; 16(5):R205. PubMed ID: 23095370
    [Abstract] [Full Text] [Related]

  • 27. Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates.
    Oudemans-van Straaten HM, van Schilfgaarde M, Molenaar PJ, Wester JP, Leyte A.
    Crit Care; 2009 Oct 24; 13(6):R193. PubMed ID: 19958532
    [Abstract] [Full Text] [Related]

  • 28. Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalities.
    Schilder L, Nurmohamed SA, ter Wee PM, Paauw NJ, Girbes AR, Beishuizen A, Beelen RH, Groeneveld AB.
    BMC Nephrol; 2015 Oct 30; 16():178. PubMed ID: 26519056
    [Abstract] [Full Text] [Related]

  • 29. Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury.
    Liu DL, Huang LF, Ma WL, Ding Q, Han Y, Zheng Y, Li WX.
    Chin Med J (Engl); 2016 Jul 20; 129(14):1682-7. PubMed ID: 27411455
    [Abstract] [Full Text] [Related]

  • 30. Prediction of major adverse kidney events in critically ill burn patients.
    Dépret F, Boutin L, Jarkovský J, Chaussard M, Soussi S, Bataille A, Oueslati H, Moreno N, de Tymowski C, Parenica J, Benešová K, Vauchel T, Ferry A, Benyamina M, Cupaciu A, Coutrot M, Garnier JP, Serror K, Chaouat M, Mebazaa A, Legrand M, PRONOBURN group.
    Burns; 2018 Dec 20; 44(8):1887-1894. PubMed ID: 30322739
    [Abstract] [Full Text] [Related]

  • 31. Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatricRIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery: cross-sectional study*.
    Ricci Z, Netto R, Garisto C, Iacoella C, Favia I, Cogo P.
    Pediatr Crit Care Med; 2012 Nov 20; 13(6):667-70. PubMed ID: 22895007
    [Abstract] [Full Text] [Related]

  • 32. Plasma proenkephalin and neutrophil gelatinase-associated lipocalin predict mortality in ICU patients with acute kidney injury.
    Zhang M, Yang Y, Zhu L, Cui K, Zhang S, Xu Y, Jiang Y.
    BMC Nephrol; 2024 May 22; 25(1):181. PubMed ID: 38778257
    [Abstract] [Full Text] [Related]

  • 33. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
    Swart EL, de Jongh J, Zuideveld KP, Danhof M, Thijs LG, Strack van Schijndel RJ.
    Am J Kidney Dis; 2005 Feb 22; 45(2):360-71. PubMed ID: 15685515
    [Abstract] [Full Text] [Related]

  • 34. Neutrophil Gelatinase Associated Lipocalin (NGAL) in Leptospirosis Acute Kidney Injury: A Multicenter Study in Thailand.
    Srisawat N, Praditpornsilpa K, Patarakul K, Techapornrung M, Daraswang T, Sukmark T, Khositrangsikun K, Fakthongyoo A, Oranrigsupak P, Praderm L, Suwattanasilpa U, Peerapornratana S, Loahaveeravat P, Suwachittanont N, Wirotwan TO, Phonork C, Kumpunya S, Tiranathanagul K, Chirathaworn C, Eiam-ong S, Tungsanga K, Sitprija V, Kellum JA, Townamchai N, Thai Lepto-AKI study group.
    PLoS One; 2015 Feb 22; 10(12):e0143367. PubMed ID: 26629810
    [Abstract] [Full Text] [Related]

  • 35. Phenytoin removal by continuous venovenous hemofiltration.
    Oltrogge KM, Peppard WJ, Saleh M, Regner KR, Herrmann DJ.
    Ann Pharmacother; 2013 Sep 22; 47(9):1218-22. PubMed ID: 24259740
    [Abstract] [Full Text] [Related]

  • 36. Effects of continuous renal replacement therapy on serum cytokines, neutrophil gelatinase-associated lipocalin, and prognosis in patients with severe acute kidney injury after cardiac surgery.
    Wang HJ, Wang P, Li N, Wan C, Jiang CM, He JS, Wang DJ, Zhang M, Sun LY.
    Oncotarget; 2017 Feb 07; 8(6):10628-10636. PubMed ID: 27833089
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ, Jennings AC, Thomson AH, Creed G, Beale RJ, McLuckie A.
    Crit Care Med; 2000 Mar 07; 28(3):632-7. PubMed ID: 10752806
    [Abstract] [Full Text] [Related]

  • 38. Validation of plasma neutrophil gelatinase-associated lipocalin as a biomarker for diabetes-related acute kidney injury.
    Bufkin KB, Karim ZA, Silva J.
    Sci Prog; 2024 Mar 07; 107(4):368504241288776. PubMed ID: 39360481
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
    Boucher BA, Hudson JQ, Hill DM, Swanson JM, Wood GC, Laizure SC, Arnold-Ross A, Hu ZY, Hickerson WL.
    Pharmacotherapy; 2016 Dec 07; 36(12):1229-1237. PubMed ID: 27862103
    [Abstract] [Full Text] [Related]

  • 40. Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis.
    Vanmassenhove J, Glorieux G, Lameire N, Hoste E, Dhondt A, Vanholder R, Van Biesen W.
    BMC Nephrol; 2015 Feb 13; 16():18. PubMed ID: 25868473
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.